# \[The influence of 6-months treatment with exenatide on type 2 diabetes mellitus compensation, anthropometric and biochemical parameters\].

> PubMed lists PMID 20184107 in Vnitrni lekarstvi as Clinical Trial, Journal Article, with publication-date metadata of 2010-01 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-20184107-exenatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-20184107-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-20184107-exenatide-v1.json
- Content SHA-256: `288f353e7e9a74a04d81a3667375ddf8fbda71dd49a0e831de1175383a58129c`

## Claims and source pins

### Headline

\[The influence of 6-months treatment with exenatide on type 2 diabetes mellitus compensation, anthropometric and biochemical parameters\]. ([`pubmed-observation-pmid-20184107-2026-01-28-31afee16a582`](#source-pubmed-observation-pmid-20184107-2026-01-28-31afee16a582))

### Summary

PubMed lists PMID 20184107 in Vnitrni lekarstvi as Clinical Trial, Journal Article, with publication-date metadata of 2010-01 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-20184107-2026-01-28-31afee16a582`](#source-pubmed-observation-pmid-20184107-2026-01-28-31afee16a582))

### Paragraph 1

PubMed lists PMID 20184107 in Vnitrni lekarstvi as Clinical Trial, Journal Article, with publication-date metadata of 2010-01 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-20184107-2026-01-28-31afee16a582`](#source-pubmed-observation-pmid-20184107-2026-01-28-31afee16a582))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-20184107-2026-01-28-31afee16a582`](#source-pubmed-observation-pmid-20184107-2026-01-28-31afee16a582))

## Sources

<a id="source-pubmed-observation-pmid-20184107-2026-01-28-31afee16a582"></a>
- **\[The influence of 6-months treatment with exenatide on type 2 diabetes mellitus compensation, anthropometric and biochemical parameters\]. · retained source version 1:2026-01-28:current:31afee16a5824fbd33eee0647b8c80717425ad150ec35a3e9277cf163bee5cf5** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/20184107/) (`pubmed-observation-pmid-20184107-2026-01-28-31afee16a582`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "\[The influence of 6-months treatment with exenatide on type 2 diabetes mellitus compensation, anthropometric and biochemical parameters\]." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-20184107-exenatide-v1.json SHA-256: 288f353e7e9a74a04d81a3667375ddf8fbda71dd49a0e831de1175383a58129c.